Blog
RSS FeedPosted by Michael Wonder on 29 Nov 2017
Over-reliance in cardiovascular treatment – a supply risk that needs to change
29 November 2017 - New Zealand’s reliance on the cardiovascular medicines metoprolol succinate and cilazapril is out of step with ...
Posted by Michael Wonder on 23 Nov 2017
Treating hepatitis C in New Zealand
23 November 2017 - General practice has a real opportunity to significantly lead the way to treat people in the ...
Posted by Michael Wonder on 22 Nov 2017
New Zealand cancer patients renew call for more funded medicines, as report reveals 682 million dollar 'hole'
22 November 2017 - Cancer patients say they are sick of paying for their own survival after an independent report ...
Posted by Michael Wonder on 19 Nov 2017
More than $150,0000 spent on mysterious 'Election 2017 project' by drug lobby group
19 November 2017 - A 'big pharma' lobby group has sunk more than $150,000 into a mysterious scheme called "Election ...
Posted by Michael Wonder on 16 Nov 2017
NZAF welcomes PHARMAC’s milestone proposal to fund pre-exposure prophylaxis
16 November 2017 - In a proposal released this week, PHARMAC has announced its intention to fund the HIV-prevention drug ...
Posted by Michael Wonder on 15 Nov 2017
Proposal to widen funded access to pulmonary arterial hypertension treatments
15 November 2017 - PHARMAC is seeking feedback on a proposal to make several changes to the funding of medicines ...
Posted by Michael Wonder on 15 Nov 2017
Sarah Fitt appointed as PHARMAC Chief Executive
15 November 2017 - Stuart McLauchlan Chair PHARMAC today announced that Sarah Fitt, Director of Operations will be appointed as ...
Posted by Michael Wonder on 14 Nov 2017
Steffan Crausaz stepping down as PHARMAC Chief Executive
14 November 2017 - PHARMAC has announced today that its Chief Executive, Steffan Crausaz, will be stepping down to take ...
Posted by Michael Wonder on 14 Nov 2017
Proposal to widen access to various anti-infectives
14 November 2017 - PHARMAC is seeking feedback on three proposals to widen funded access, from 1 January 2018, to ...
Posted by Michael Wonder on 14 Nov 2017
Proposal to fund HIV pre-exposure prophylaxis (PrEP)
14 November 2017 - PHARMAC is seeking feedback on a proposal to widen funded access to emtricitabine with tenofovir disoproxil fumarate ...
Posted by Michael Wonder on 09 Nov 2017
'Mind the gap' revisited
6 November 2017 - John Zalcberg and I note with interest the article by Evans et al recently published in ...
Posted by Michael Wonder on 08 Nov 2017
Proposal to list methylnaltrexone bromide
8 November 2017 - PHARMAC is seeking feedback on a proposal to list methylnaltrexone bromide (Relistor) 12 mg/0.6 mL injection in ...
Posted by Michael Wonder on 31 Oct 2017
Fund for next generation medicines investigated
1 November 2017 - A fund to give Kiwis quicker access to new-generation medicines will be investigated by the Government, ...
Posted by Michael Wonder on 31 Oct 2017
New Zealand Pharmaceutical Schedule - 1 November 2017
1 November 2017 - The November 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 31 Oct 2017
Proposal to widen access to zoledronic acid for early breast cancer
31 October 2017 - PHARMAC proposes to widen funded access to zoledronic to include adjuvant use in post-menopausal women with ...